Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Nature Communications
|
December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O Sambo, Min Lin, Anthony Owens, et al.
Journal of Clinical Pharmacology
|
April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis
Yanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Journal of Neuropathology and Experimental Neurology
|
December 22, 2010
Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29
Richard S Bedlack, Angela Genge, Anthony A Amato, et al.
Neurology
|
May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar, Lanyu Zhang, Lily Wang, et al.
The American Journal of Gastroenterology
|
November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Zachary Macchi, Yunxia Wang, Dan Moore, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 5, 2011
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
Kenneth C Gorson, Ivo N van Schaik, Ingemar S J Merkies, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
Lancet (London, England)
|
March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
Anne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Behavioural Neurology
|
December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients
Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Nature Communications
|
December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O Sambo, Min Lin, Anthony Owens, et al.
Journal of Clinical Pharmacology
|
April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis
Yanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Journal of Neuropathology and Experimental Neurology
|
December 22, 2010
Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29
Richard S Bedlack, Angela Genge, Anthony A Amato, et al.
Neurology
|
May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar, Lanyu Zhang, Lily Wang, et al.
The American Journal of Gastroenterology
|
November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Zachary Macchi, Yunxia Wang, Dan Moore, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 5, 2011
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
Kenneth C Gorson, Ivo N van Schaik, Ingemar S J Merkies, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
Lancet (London, England)
|
March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
Anne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Behavioural Neurology
|
December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients
Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Page
of 9